Ironwood Pharmaceuticals Inc (IRWD) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
Ironwood Pharmaceuticals Inc (IRWD) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($74.58 Million) in capital expenditures ($1.00K). See IRWD free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$74.58 Million
USD
Capital Expenditures
$1.00K
USD
Data as of
Dec 2025
Most recent filing
Ironwood Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Ironwood Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Ironwood Pharmaceuticals Inc from 2019 to 2025. For live market cap and broader valuation context, see IRWD stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $127.04 Million | $34.00K | ▼ -80.5% |
| 2024 | 0.00x | $103.55 Million | $142.00K | ▼ -7.9% |
| 2023 | 0.00x | $183.43 Million | $273.00K | ▲ +199.6% |
| 2022 | 0.00x | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.01x | $168.84 Million | $1.84 Million | ▼ -98.4% |
| 2019 | 0.67x | $10.72 Million | $7.19 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow